Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies.
作者信息
Favresse Julien, Eucher Christine, Elsen Marc, Tré-Hardy Marie, Dogné Jean-Michel, Douxfils Jonathan
机构信息
Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.
Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, Belgium.
出版信息
Clin Chem. 2020 Aug 1;66(8):1104-1106. doi: 10.1093/clinchem/hvaa131.
Abstract
摘要
相似文献
1
Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies.用于检测新型冠状病毒2型总抗体的罗氏电化学发光免疫分析法的临床性能
Clin Chem. 2020 Aug 1;66(8):1104-1106. doi: 10.1093/clinchem/hvaa131.
2
Clinical Performance of the Roche SARS-CoV-2 Serologic Assay.罗氏新冠病毒血清学检测的临床性能
Clin Chem. 2020 Aug 1;66(8):1107-1109. doi: 10.1093/clinchem/hvaa132.
3
Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.一种电化学发光SARS-CoV-2抗体检测方法的评估
J Appl Lab Med. 2020 Nov 1;5(6):1313-1323. doi: 10.1093/jalm/jfaa134.
4
Preliminary evaluation of Roche Cobas Elecsys Anti-SARS-CoV-2 chemiluminescence immunoassay.罗氏 Cobas Elecsys 抗 SARS-CoV-2 化学发光免疫分析的初步评估
Clin Chem Lab Med. 2020 Oct 25;58(11):e251-e253. doi: 10.1515/cclm-2020-1042.
5
Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.两种严重急性呼吸综合征冠状病毒2血清学检测方法的直接比较
J Appl Lab Med. 2020 Nov 1;5(6):1351-1357. doi: 10.1093/jalm/jfaa125.
6
Clinical Performance of Two SARS-CoV-2 Serologic Assays.两种 SARS-CoV-2 血清学检测方法的临床性能。
Clin Chem. 2020 Aug 1;66(8):1055-1062. doi: 10.1093/clinchem/hvaa120.
7
Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.用于检测新型冠状病毒肺炎的严重急性呼吸综合征冠状病毒2血清学检测方法的多平台比较
J Appl Lab Med. 2020 Nov 1;5(6):1324-1336. doi: 10.1093/jalm/jfaa139.
8
Labs scramble to produce new coronavirus diagnostics.各实验室纷纷加紧生产新型冠状病毒诊断工具。
Science. 2020 Feb 14;367(6479):727. doi: 10.1126/science.367.6479.727.
9
Serological characteristics of COVID-19 patients.新型冠状病毒肺炎患者的血清学特征
Infect Dis (Lond). 2020 Oct;52(10):749-750. doi: 10.1080/23744235.2020.1784997. Epub 2020 Jun 30.
10
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.多中心评估两种化学发光和三种侧向流动免疫分析用于 COVID-19 的诊断，并评估台湾地区 SARS-CoV-2 抗体的动态反应。
Emerg Microbes Infect. 2020 Dec;9(1):2157-2168. doi: 10.1080/22221751.2020.1825016.
引用本文的文献
1
Reflections on COVID-19: A Literature Review of SARS-CoV-2 Testing.关于新冠疫情的思考：严重急性呼吸综合征冠状病毒2检测的文献综述
Vaccines (Basel). 2024 Dec 26;13(1):9. doi: 10.3390/vaccines13010009.
2
Validation of Roche immunoassay for severe acute respiratory coronavirus 2 in South Africa.罗氏针对南非严重急性呼吸综合征冠状病毒2免疫测定法的验证。
S Afr J Infect Dis. 2021 Jul 26;36(1):286. doi: 10.4102/sajid.v36i1.286. eCollection 2021.
3
Vaccine-induced humoral response of BNT162b2 and mRNA-1273 against BA.1, BA.5, and XBB.1.5. (sub)variants 6 months after a homologous booster: is immunogenicity equivalent?同源加强免疫6个月后，BNT162b2和mRNA-1273针对BA.1、BA.5和XBB.1.5（亚）变体的疫苗诱导体液反应：免疫原性是否等同？
Heliyon. 2024 Aug 10;10(16):e36116. doi: 10.1016/j.heliyon.2024.e36116. eCollection 2024 Aug 30.
4
Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS-CoV-2 Variants: A Case Report Study with Comparison to a Vaccinated Population.替沙格韦单抗联合西加韦单抗（AZD7442）对不同严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体的中和能力评估：一项与接种疫苗人群对比的病例报告研究
Case Rep Infect Dis. 2024 Aug 31;2024:9163490. doi: 10.1155/2024/9163490. eCollection 2024.
5
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection?抗SARS-CoV-2 S/N IgG/IgM抗体是否总能预测既往SARS-CoV-2感染？
Adv Lab Med. 2023 Mar 24;4(2):175-184. doi: 10.1515/almed-2023-0008. eCollection 2023 Jun.
6
Validation of a rapid SARS-CoV-2 antibody test in general practice.在全科医学中验证一种快速 SARS-CoV-2 抗体检测方法。
BMJ Open. 2023 May 2;13(5):e069997. doi: 10.1136/bmjopen-2022-069997.
7
Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome.一名83岁患有疫苗诱导的血栓形成伴血小板减少综合征的女性对ChadOx1 nCoV-19疫苗的抵抗情况
Vaccines (Basel). 2022 Nov 30;10(12):2056. doi: 10.3390/vaccines10122056.
8
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
9
Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunity.比较两种抗体筛选系统在康复和接种人群中 SARS-CoV-2 抗体检测的性能 - 测试性能和可能的免疫指标。
J Clin Virol. 2022 Dec;157:105322. doi: 10.1016/j.jcv.2022.105322. Epub 2022 Oct 17.
10
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity.用于确定 COVID-19 严重程度的血清 SARS-CoV-2 抗原。
Viruses. 2022 Jul 28;14(8):1653. doi: 10.3390/v14081653.
Zotero 插件